0Suppliers
0Customers
2Debt Items
10Related Chains
Krystal Biotech, Inc. Suppliers
No suppliers on recordKrystal Biotech, Inc. has not yet been matched to upstream suppliers in our database, or is still being processed.
Krystal Biotech, Inc. Customers
No clients on recordNo downstream customers found in our database for Krystal Biotech, Inc..
Krystal Biotech, Inc. Debt Obligations
| Instrument | Description | Confidence | Evidence |
|---|
| KRYS-DEBT-10572 |
Xbrl Convertible |
90%
|
xbrl convertible detail from xbrl 2017-12-31. |
| KRYS-DEBT |
Debt stack $9.1M |
90%
|
Market cache reports total debt of $9.1M. |
Krystal Biotech, Inc. Acquisitions
No acquisitions on recordNo completed or pending acquisitions found in our database for Krystal Biotech, Inc..
Krystal Biotech, Inc. Ownership
| Holder | Name | Confidence | Evidence |
|---|
| KRYS-OWNER-AVORO-CAPITAL-ADVISORS-LLC |
Avoro Capital Advisors LLC |
90%
|
13F overlay lists Avoro Capital Advisors LLC as top holder; 370 tracked holders. |
Krystal Biotech, Inc. Extended Supply Chain Network
| Ticker | Name | Chain Index | Hops | Relationship Types |
|---|
| BEAM |
Beam Therapeutics Inc. |
100.00 |
2 |
|
| LLY |
Eli Lilly and Company |
100.00 |
2 |
|
| NVSEF |
Novartis AG |
100.00 |
2 |
|
| WVE |
Wave Life Sciences Ltd. |
100.00 |
2 |
|
| GRFS |
Grifols, S.A. |
100.00 |
2 |
|
| KRRO |
Korro Bio, Inc. |
100.00 |
2 |
|
| SNYNF |
Sanofi |
100.00 |
2 |
|
| MREO |
Mereo BioPharma Group plc |
36.29 |
1 |
['spend'] |
| AZN |
AstraZeneca PLC |
13.97 |
2 |
|
| NVS |
Novartis AG |
13.97 |
2 |
|
